Improvement in HPLC fractionation of thyroxine-containing thyroglobulin tryptic peptides by prior Accell ion-exchange column chromatography  by Miguel, J. et al.
Volume 232, number 2, 399-404 FEB 05895 May 1988 
Improvement in HPLC fractionation of thyroxine-containing 
thyroglobulin tryptic peptides by prior Accell ion-exchange column 
chromatography 
J. Miguel, M. Asuncion, C. Marin, A. Seguido, L. Lamas and E. Mendez* 
Unidad de Endocrinologia, Institute de Investigaciones Biomkdicas, CSIC and Facultad de Medicina, 
Universidad Autdnoma de Madrid and *Servicio de Endocrinologia, Centro Ram6n y Cajal, 28034 Madrid, Spain 
Received 13 February 1988; revised version received 18 March 1988 
The isolation and purification of the peptides containing the hormonogenic tyrosyl residues in thyroglobulin is of great 
interest o the understanding of structure-function relationships in this iodoprotein. This is usually performed in reduced 
alkylated selectively hydrolyzed thyroglobulin by subsequent HPLC fractionation. However, the main difficulty encoun- 
tered when trying to isolate these peptides is their disproportion with respect o the total number of possible peptides 
(14 vs a total of 508). Several HPLC runs with different mobile phases are necessary and each run is accompanied with 
significant losses of the peptides to be purified. In an attempt o improve the separation of the TCcontaining peptides 
in thyroglobulin tryptic digests from the much more abundant iodotyrosinetontaining ones, which are present as con- 
taminants, we have used a very simple and fast step prior to the HPLC fractionation as it is a self-packed ion-exchange 
column chromatography. This preliminary step results in an improvement in the separation of these peptides and leads 
to a relative enrichment of the hormonogenic peptides falling in different zones of the HPLC chromatogram, which facili- 
tates their subsequent separation and purification by HPLC. 
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1. INTRODUCTION 
The biosynthesis of the thyroid hormones, 
thyroxine and triiodothyronine, takes place within 
the polypeptide chains of thyroglobulin, the pro- 
thyroid hormone. Tg is a huge glycoprotein 
(660 kDa, 19 S) composed of two identical 
subunits (330 kDa, 12 S). Due to the size of the Tg 
molecule, the determination of its primary struc- 
ture by conventional techniques of protein 
chemistry was practically an unapproachable task. 
However, advances in DNA-recombinant tech- 
niques have made it recently possible [1,2]. The 
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availability of Tg’s primary structure has again en- 
couraged studies on structure-function relation- 
ships, because it has been shown to have a striking 
interspecies conservation of its hormonogenic do- 
mains [3]. The Tg subunit has 2750 amino acids 
and a signal peptide with 19 amino acids in front 
of the N-terminal region. Each subunit has 72 
tyrosyl (Tyr) residues which, considering their size, 
is not a high number but rather average. Of the 144 
Tyr residues contained in the Tg molecule, only 
about 25% are accessible to iodination, and of 
those 36 are iodinated as mono- and diiodotyrosine 
(MIT and DIT, respectively), approx. 40% (a max- 
imum of 14 hormonogenic Tyr residues) directly 
participate in hormone formation. Half of them 
provide the iodothyronine inner ring (‘acceptors’) 
and the other half provide the outer iodothyronine 
ring (‘donors’), leaving behind a dehydroalanine 
chain to form a maximum of 6-7 hormone 
residues/m01 Tg after the peroxidase-catalyzed 
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coupling. By reduction-alkylation of Tg from 
several species, hormone-rich peptides (‘hor- 
monogenic peptides’) have been isolated [4,5]. 
These peptides have been fractionated and purified 
by HPLC [6] after hydrolysis with various selective 
proteolytic agents (trypsin, CNBr, etc.), sequenced 
and located within the primary structure of Tg by 
comparison of the sequence found with that de- 
rived from the Tg cDNA [7]. Up to now, four main 
hormonogenic sites have been identified in rabbit 
and human Tg corresponding to Tyr residue 
numbers: 5, 1291, 2555 and 2748 [8]. However, 
due to the high molecular size of Tg, the purifica- 
tion of these peptides is very laborious since, in 
order to separate them from the more abundant 
contaminating peptides, many HPLC runs with 
various mobile phases are required and the yield is 
very low. In trying to improve this procedure, in 
this study, we subjected the tryptic digests, prior to 
the HPLC fractionation, to Accell self-packed 
cation (CM)- and anion (QMA)-exchange chro- 
matography, eluting the columns with a volatile 
solvent [9]. The passage through ion-exchange 
columns results in the enrichment of T6containing 
peptides, greatly facilitating their subsequent frac- 
tionation and purification by HPLC. 
2. MATERIALS AND METHODS 
2.1. Thyroglobulin 
The iodine poor human goiter Tg was kindly provided by Dr 
John T. Dunn (University of Virginia, Charlottesville, USA). It 
was prepared from a long standing non-toxic multinodular 
goiter by filtration of the 100000 x g supernate on a Bio-Gel 
A-5m column [4]. Its iodine content was 0.09% I, corre- 
sponding to approx. 4 atoms of iodine per molecule. The molar 
concentration of Tg was determined from A2s0~ measurements 
using Azso = 10.0 cm -’ and a molecular mass of 660 kDa. 
2.2. Enzymatic iodination 
The reaction mixture contained per ml: 5 FM Tg, 1.25 X 
10e4 M iodide labeled with radioiodine (I* from Amersham, 
SA 1 pCi/patom), 7.5 fig lactoperoxidase (&12/280 = 0.8; 
Sigma), 60pmol phosphate buffer, pH 7.0, and an 
H202-generating system, formed by 5 mg glucose monohydrate 
(Merck) and 18.75 mU of glucose oxidase (92.5 U/mg; Boeh- 
ringer). Incubation was carried out at 37°C for 30 min and the 
reaction was started with the addition of glucose oxidase and 
stopped by addition of 25 ~1 of 10% NpNa keeping the tubes on 
ice. 5 pl of each sample were used for separation of the I* 
bound to Tg from that remaining as free iodide by ascending 
short term paper chromatography on n-butanol/ethanol/l M 
ammonia (5 : 1: 2, by vol.) in Whatman 3MM paper strips. The 
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number of atoms of iodine bound to the protein and the 
number of residues of each iodoamino acid per molecule of Tg 
was calculated after pronase digestion and paper 
chromatography as previously described [lo,1 11. 
2.3. Reduction, alkylation and trypsin digestion of in vitro 
iodinated thyroglobulin 
The Tg samples were reduced at room temperature for 4 h at 
pH 9.5 with 2-mercaptoethanol (Serva) assuming 100 disulfide 
groups per mole of Tg and using an ME/disulfide group molar 
ratio of 100: 1. Subsequently, the reduced protein was adjusted 
to pH 8.0 and alkylated at room temperature for 30 min with 
acrylonitrile (Merck) using an acrylonitrile/ME molar ratio of 
2: 1. The reaction was stopped by adding twice as much ME 
than acrylonitrile used for alkylation. The excess reagents were 
eliminated by overnight dialysis against 0.02% ammonium 
bicarbonate (May & Baker). The dialyzed reduced alkylated Tg 
was then subjected to treatment with TPCK trypsin (Sigma) us- 
ing a 5 % (w/w) solution in 1% ammonium bicarbonate, 0.1% 
SDS for 16 h at 37°C. 
2.4. Fractionation of tryptic digest from iodinated Tg with 
Accell ion-exchange columns 
The reduced, carboxymethylated Tg tryptic digests were 
divided into three aliquots (approx. 1.1 mg each): (i) the control 
sample subjected directly to HPLC fractionation; (ii) the sam- 
ple passed through a self-packed Accell CM cation-exchange 
(carboxymethyl) column (0.8-4 cm); and (iii) the sample passed 
through a self-packed Accell QMA anion-exchange (quaternary 
methylammonium) column (0.8-4 cm), both from Waters, ac- 
cording to the scheme in fig. 1. The columns were equilibrated 
with 4.5 ml of 0.05 M ammonium acetate buffer, pH 5.0. The 
samples were subsequently eluted from the columns with 4.5 ml 
of 20%, 50070, 80% acetonitrile in 0.05 M ammonium acetate 
buffer, pH 5.0. Finally the columns were washed with 4.5 ml of 
0.4 M NaCl. The eluates were desiccated on a rotavapor and 
were subsequently subjected to HPLC fractionation (see fig.1). 
2.5. Reverse-phase HPLC fractionation of the control sample 
and the CM and QMA ion-exchange eluates 
Aliquots from the different pools were dissolved in 5% 
acetonitrile containing 0.7% ammonium bicarbonate (phase A) 
and were applied on a Cl8 FBondapak reverse-phase column 
using a chromatograph consisting of 2 Waters M6000 A pumps, 
a 680 automated gradient controller and a Waters 480 variable 
wavelength absorbance detector. The column was eluted over 
110 min with a linear gradient of 5% phase B to 100% phase 
B (100% acetonitrile). The column was run at room 
temperature at a flow rate of 0.5 ml/min collecting 0.5 ml frac- 
tions. Ultrapure water for high-performance liquid chroma- 
tography, generated by a RQCcoupled to a Milli-Q water 
purification system (Millipore) was used in the preparation of 
the mobile phases which were always degassed prior to use. 
After HPLC fractionation, pronase digestion followed by 
paper chromatography was performed in most fractions to 
determine the iodoamino acid distribution and more specifically 
the T4 contained in them. 
2.6. Presentation of results 
The experiments were performed three times and were 
reproducible. 
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3. RESULTS 
Table 1 summarizes the iodine atoms bound per 
molecule of Tg, the [1251]iodoamino acid distribu- 
tion and the number of residues of each iodoamino 
acid formed by in vitro enzymatic iodination. The 
yield of coupling was fairly good since as much as 
1.0 T4 and 0.1 T3 residues were formed. As men- 
tioned above, fig.1 summarizes the procedure 
followed in order to test whether ion-exchange col- 
umn chromatography, prior to HPLC fractiona- 
tion of the Tg tryptic digests, enhances the 
separation and subsequent purification of the 
TCcontaining peptides. Table 2 compares the 
recovery of 1251-containing peptides, of total 
T4-containing peptides and their fractionation by 
HPLC from the Tg tryptic digests in the control 
sample and in those subjected to self-packed ion- 
exchange column chromatography prior to HPLC. 
As expected, this preliminary separative step 
resulted in a fractionation of the tryptic digest 
which, as seen in the left column of table 2, is dif- 
ferent for the sample applied to the CM column 
than for the one applied to the QMA column: in 
the first one, 67.5% of the ‘251-labeled material 
was not retained and 23.4% eluted with 20% 
acetonitrile, accounting between them for more 
than 90% of the 1251-tryptic digest applied to the 
column. In the QMA column, however, 34.9% 
was not retained and 19.7% eluted with 20% 
acetonitrile, accounting between them for only 
54.6% of the tryptic digest applied. While in the 
CM column almost nothing eluted with 0.4 M 
NaCl, in the QMA one, 34.9% eluted with this 
salt. As shown in the second column of table 2, in 
the CM column the unretained material contained 
38.9% of the total T4 in the digest and, more strik- 
ingly, the one eluted with 20% acetonitrile, which, 
as already mentioned, contained only 23.4% of the 
1251-material, had 44.9% of the total T4 in the 
digest. In other words, it was TCenriched with 
respect o the control sample. Again the QMA col- 
umn worked differently with respect to the 
T6containing peptides: the unretained material 
contained 10.6% of the total T4 and the only 
T4-enriched eluate was that with 50% acetonitrile 
which, having only 8.2% of the ‘251-material, con- 
tained 21.8% of the T4 and the eluate with 0.4 M 
NaCl which, having 34.9% of the 1251, contained 
as much as 51.9% of the T4 in the tryptic digest. 
Fig.2 shows the HPLC fractionation pattern of 
both the “‘1 peptides from the Tg tryptic digests 
(left ordinate) and the T4 distribution among them 
expressed as per cent of the total T4 in the digests 
(right ordinate) for the control and some of the 
samples which showed T4 enrichment. Fig.2A 
shows the pattern corresponding to the control 
sample. Though there is a widespread distribution 
of the ‘251-tryptic peptides, most of the ones con- 
taining T4 are separated between fractions 38 and 
70 of the HPLC chromatogram. Two main zones 
are seen: zone 1 (between fractions 37 and 57) and 
zone 2 (between fractions 58 and 70). According to 
this arbitrary distribution, it can be seen in table 2 
that the T4 in the control sample is almost evenly 
distributed between these two zones and very little 
T4 is found elsewhere in the HPLC 
chromatogram. Fig.2B shows the pattern cor- 
responding to the CM unretained material. It can 
be seen that, in comparison with the control sam- 
ple, the late eluting 12sI-material has been excluded 
from this eluate and there is only a single T4 peak 
which, as also shown in table 2, falls almost com- 
pletely in zone 1, so that there is an enrichment of 
the TCcontaining peptides separating within zone 
1. Fig.2C shows the pattern corresponding to the 
CM eluate with 20% acetonitrile in which the late 
eluting material has not been excluded. Again in 
table 2 it can be seen that more than half of the 
TCcontaining peptides fall in zone 1 but there is 
Table 1 
Degree of iodination, [‘251]iodoamino acid distribution and number of residues formed per molecule by in 
vitro enzymatic iodination of iodine poor (0.09%) thyroglobulin (for more details see text) 
Atoms I/ [‘251]Iodoamino acid distribution Residues/molecule Tg 
molecule Tg 
% DIT “70 MIT Vo T4 Vo T3 DIT MIT T4 T3 
23.3 27.7 39.2 17.3 1.5 3.2 9.1 1.0 0.11 
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Fig. 1. Outline of the procedure used for testing the improvement in separation of T4-containing peptides from thyroglobulin tryptic 
digests by self-packed ion-exchange column chromatography (for more details see text). 
Table 2 
Recovery of ‘?-containing peptides, of T6containing peptides and their location in the HPLC chromatogram in 
Tg tryptic digests after self-packed CM- and QMA-exchange chromatography and elution with various solvents 
Sample Vo total “‘1 HPLC separation of T6containing peptides 
Vo total T4 T4 location 



















0.4 M NaCl 
100 100 54.3 
67.5 38.9 95.2 










34.9 10.6 40.7 - 61.3 
19.7 15.6 91.6 - 2.4 
8.2 21.8 35.5 59.9 4.6 
2.0 - nd nd nd 
34.9 51.9 64.4 - 35.6 
nd, not determined 
402 




























0 20 40 60 80 100 0 20 40 60 80 100 






















6 6 g 
i 





Fig.2. Separation of tryptic peptides of in vitro iodinated (12’1) thyroglobulin by reverse-phase HPLC on a Cl8 ,uBondapak column. 
Gradient from 5% to 100% phase B over 110 min. Flow rate 0.5 ml/min. (e---e) Percent of total lz51 in the chromatogram, ( M) 
T4-containing fractions in the chromatogram after pronase digestion and paper chromatography of aliquots of each fraction, expressed 
as percent of the total T4 in the control. 
also about one fourth which falls now in zone 2. the TCcontaining peptides fall almost completely 
Given the small amount of material eluting in the in zone 1, as seen also in table 2. Fig.2E shows the 
CM column with 50 and 80% acetonitrile and with pattern corresponding to the QMA 50% 
0.4 M NaCl, no attempt was made to fractionate acetonitrile eluate which excluded both most of the 
them by HPLC. Fig.2D shows the pattern cor- early and the late eluting material. As can be seen 
responding to the material eluting with 20% also in table 2, more than half of its TCcontaining 
acetonitrile from the QMA column. In this case, peptides fall in zone 2. Finally, fig.2F shows the 
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pattern of the QMA 0.4 M NaCl eluate which 
almost totally excluded the late eluting material. 
As can also be seen in table 2 more than half of its 
TCcontaining peptides fall in zone 1. 
4. DISCUSSION 
Due to the large size of the Tg molecule, the 
total number of peptides is very high compared 
with the low number of hormonogenic peptides (in 
bovine Tg there are 508 possible tryptic peptides 
but there are only 8-14 directly involved in thyroid 
hormone formation) and the purification by 
HPLC fractionation of the latter from the con- 
taminating peptides is very laborious. A high 
number of HPLC runs is necessary and since each 
run is accompanied with significant losses of the 
material to be purified, it is desirable to Iimit the 
number of runs as much as possible. In an attempt 
to improve the separation and subsequent purifica- 
tion of the T6containing tryptic peptides from the 
contaminating ones in Tg, we thought that the use 
of a preliminary simple step, such as a self-packed 
ion-exchange column chromatography [9], could 
be useful prior to the HPLC fractionation steps. 
As shown here, ion-exchange column chromatog- 
raphy of the Tg tryptic digests leads to the separa- 
tion of various fractions in which not only some 
enrichment of the overall TCcontaining peptides 
was seen but also a selective nrichment of some of 
the TCcontaining zones. For instance, the cationic 
unretained material and the 20% acetonitrile 
eluate together with the anionic 20% acetonitrile 
and 0.4 M NaCl eluates lead to an enrichment of 
the TCcontaining peptides falling in zone 1, while 
the anionic 50% eluate leads to an enrichment of 
the TQcontaining peptides falling in zone 2. 
Though the isolation and purification of the T4- 
containing peptides in either of the arbitrarily 
defined zones 1 and 2 was beyond the scope of this 
paper, according to our experience in separating 
Tg tryptic peptides by HPLC [ 121 it is possible that 
those zones correspond to different hormonogenic 
peptides. On the other hand, the enrichment of 
TCcontaining peptides was only relative since no 
complete separation of the two zones was achieved 
by ion-exchange chromatography. It is possible 
that connecting or combining the CM and QMA 
columns [9] could improve the separation and 
enrichment of the T4-containing peptides. This 
will have to be tested for each case according to the 
particular characteristics of the specimen analyzed. 
We believe that even if, as mentioned above, the 
enrichment of T4-containing peptides was only 
relative, the use of ion-exchange chromatography 
represents an improvement and it can be used, as 
a preliminary step, when trying to separate and 
purify not only T4-containing peptides or ‘accep- 
tors’ but also the iodotyrosine-containing ones act- 
ing as ‘donors’ in the coupling reaction to form the 
hormones T4 and T3, since it could facilitate their 
subsequent separation and purification by HPLC. 
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